1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. DexCom, Inc.
  6. Consensus
    DXCM   US2521311074

DEXCOM, INC.

(DXCM)
  Report
Delayed Nasdaq  -  05/20 04:00:01 pm EDT
321.23 USD   +1.62%
09:04aDEXCOM INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/17Citigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
05/11TRANSCRIPT : DexCom, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 02:40 PM
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on DEXCOM, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) DEXCOM, INC.
Analyst Recommendations on DEXCOM, INC.
05/17Citigroup Adjusts DexCom's Price Target to $525 From $630, Reiterates Buy Rating
MT
04/29Raymond James Adjusts DexCom's Price Target to $486 From $538, Keeps Outperform Rating
MT
04/29Morgan Stanley Adjusts Price Target for DexCom to $492 From $514, Maintains Equalweight R..
MT
04/29SVB Leerink Adjusts DexCom's Price Target to $500 From $565, Keeps Outperform Rating
MT
04/29Piper Sandler Adjusts DexCom's Price Target to $480 From $725, Reiterates Overweight Ratin..
MT
03/02BofA Securities Reinstates DexCom at Buy With $500 Price Target
MT
02/11Morgan Stanley Cuts Price Target on DexCom to $514 From $570, Maintains Equalweight Rating
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 316,12 $
Average target price 528,29 $
Spread / Average Target 67,1%
High Price Target 600,00 $
Spread / Highest target 89,8%
Low Price Target 315,00 $
Spread / Lowest Target -0,35%
Consensus detail
Consensus revision (last 18 months)